DENVER, Colo., -- Eon, the world leader in Intelligent Care, has reached a significant milestone in its goal to save lives through early disease detection. The company has now partnered with over 1,000 hospitals and radiology centers, analyzed 414 million imaging reports, and identified more than 15.7 million abnormal findings since 2021, indicating potential risk for cancer, aneurysms, or other catastrophic conditions.

‍

Since its inception, Eon has remained steadfast in its commitment to transform the way patient care is delivered. By integrating advanced AI and clinician-designed automation into workflows, Eon's platform enables providers to identify concerning abnormalities and deliver personalized care plans with precision and efficiency. This approach has revolutionized how health systems manage disease - ensuring more patients receive timely intervention when there is the best chance of survival.

‍

In 2024 alone, Eon achieved unprecedented growth, innovation, and impact:

‍

• Scaled patient impact:
  • 550% increase in abnormalities identified across all disease states since 2021
  • 75% of abnormalities found outside of incidental lung and pancreas cohorts
  • 73% patient adherence to guideline-driven next steps (compared to the national average of 30%)
• Leading technology:
  • 130 enhancements across 28 product releases
  • 14 AI models performing above 97% precision and accuracy
  • Flawless SOC2 compliance with no exceptions
• Unparalleled customer support:
  • 97% customer renewal rate
  • 1.1 million letters, emails, and calls initiated by Eon navigators (10x growth since 2021)
  • 350k exams reviewed by Eon navigators

‍

"Our journey has been driven by a singular focus to make patients healthier and healthcare affordable," said Dr. Akrum Al-Zubaidi, CEO and Founder of Eon. "Our ability to impact millions of patients is a testament to the incredible work of our team and counterparts on the front lines who use our technology every day. Reaching this level of outsized market share and outpacing other solutions by 8-10x gives us confidence that we can continue to develop innovative, life-saving tools that make a lasting impact. We can't wait to show the world what we're planning for 2025 and beyond."

‍

Sadly, 70% of patients discharged with important abnormalities do not receive necessary follow-up care. Eon's Intelligent Care platform uses the data hospitals already have to save lives and unlock growth. Eon identifies at-risk patients, generates predicted care plans, and adjusts follow-up communications in real time. This leads to significant improvements in stage shift, patient capture, and survival rates, while reducing overall healthcare costs. By leveraging Eon's end-to-end solution and bi-directional integrations, care teams can spend less time manually going through worklists and more time focused on connecting patients to life-saving care, without adding headcount.

‍

As Eon celebrates this remarkable milestone, the company remains committed to #defydisease. To join the movement, please visit eonhealth.com.

‍

‍

About Eon

Eon is the world leader in Intelligent Care. Founded in 2015 by interventional pulmonologist Dr. Aki Al-Zubaidi, Eon was born from his first-hand experience treating patients with lung cancer. After years on the front lines, Dr. Aki saw his patients fall through the cracks whose lives could have been saved if only we had better care systems in place. Eon pairs cutting-edge healthcare intelligence with world-class human care to create sea change for both patients and hospitals.